GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guangdong Winsun Bio Pharmaceutical Co Ltd (BJSE:839729) » Definitions » Revenue

Guangdong Winsun Bio Pharmaceutical Co (BJSE:839729) Revenue : ¥280.7 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Guangdong Winsun Bio Pharmaceutical Co Revenue?

Guangdong Winsun Bio Pharmaceutical Co's revenue for the three months ended in Jun. 2024 was ¥52.7 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was ¥280.7 Mil. Guangdong Winsun Bio Pharmaceutical Co's Revenue per Share for the three months ended in Jun. 2024 was ¥0.22. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ¥1.02.

Warning Sign:

Guangdong Winsun Bio Pharmaceutical Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Guangdong Winsun Bio Pharmaceutical Co was -21.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 49.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 10 years, Guangdong Winsun Bio Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 49.00% per year. The lowest was -38.30% per year. And the median was 1.50% per year.


Guangdong Winsun Bio Pharmaceutical Co Revenue Historical Data

The historical data trend for Guangdong Winsun Bio Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Winsun Bio Pharmaceutical Co Revenue Chart

Guangdong Winsun Bio Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 331.49 332.59 363.53 348.72 314.28

Guangdong Winsun Bio Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.62 100.21 61.36 66.50 52.68

Competitive Comparison of Guangdong Winsun Bio Pharmaceutical Co's Revenue

For the Biotechnology subindustry, Guangdong Winsun Bio Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Winsun Bio Pharmaceutical Co's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guangdong Winsun Bio Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Guangdong Winsun Bio Pharmaceutical Co's Revenue falls into.



Guangdong Winsun Bio Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥280.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangdong Winsun Bio Pharmaceutical Co  (BJSE:839729) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Guangdong Winsun Bio Pharmaceutical Co Revenue Related Terms

Thank you for viewing the detailed overview of Guangdong Winsun Bio Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Winsun Bio Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 35 Tianyuan West Road, Huangpu District, Guangdong Province, Guangzhou City, CHN, 511356
Guangdong Winsun Bio Pharmaceutical Co Ltd is involved in the field of veterinary biological products. It is an enterprise integrating research and development, production, sales, and service of veterinary biological products. It engages in the production of embryotoxin live vaccines, cytotoxic live vaccines, bacterial live vaccines, avian influenza inactivated vaccines, cytotoxic inactivated vaccines, embryotoxin inactivated vaccines, bacterial inactivated vaccines, swine fever live vaccines (rabbit source); veterinary use Biological products.

Guangdong Winsun Bio Pharmaceutical Co Headlines

No Headlines